114
Participants
Start Date
December 18, 2014
Primary Completion Date
April 9, 2020
Study Completion Date
April 9, 2020
Queensland University of Technology (QUT) Institute of Health and Biomedical Innovation (IHBI), Woolloongabba
University of Pennsylvania, Center for FOP & Related Bone Disorders, Philadelphia
University of California San Francisco, Division of Endocrinology and Metabolism, San Francisco
Hospital Italiano de Buenos Aires, Department of Pediatrics, Buenos Aires
Hôpital Necker-Enfants Malades, Department of Genetics, Paris
Gaslini Institute, Unit of Rare Diseases, Department of Pediatrics, Genoa
The Royal National Orthopaedic Hospital, Brockley Hill, Stanmore
Lead Sponsor
Clementia Pharmaceuticals Inc.
INDUSTRY